CV #7(B): Raj Saini Introduced M-132, Lobbied By Big Pharma

Saini is listed many times in connection with the Lobbying Commissioner’s Office. Many of those communications reports are with pharmaceutical companies who are lobbying him.

Saini is a board member for the Canadian International Council. Here are the main founders that is lists. Some of these names should be familiar.

1. Raj Saini’s LPC Profile

A proud resident of Kitchener-Waterloo, Raj Saini has owned and operated an award-winning small business for nearly 20 years. His success as a small business owner comes from his focus on helping people achieve their health goals using evidence-based protocols to enable healing and encourage healthy lifestyles.
.
A committed and active supporter of local organizations, Raj works tirelessly to engage his community in politics and international affairs. He is a proud Rotarian of many years, a board member of the Canadian International Council, Waterloo Region branch and a long-time champion of Liberal values. He is passionate about improving the local economy, creating jobs and promoting the health and well-being of Kitchener Centre’s residents through intelligent, fiscally responsible environmental and health policy.
.
Raj earned his Bachelors of Science in Chemistry from the University of Toronto, and a Bachelors of Science in Pharmacy from Boston’s Northeastern University.

The above is taken directly from his profile. Let’s get into the issues that exist here, and why they are a problem.

2. Saini Co-Owned A Pharmacy

In 2017, Saini pandered in Parliament on the issue of World Pharmacist’s Day. No shocker, given his personal and professional stake in the industry.

KITCHENER — As a pharmacist, Raj Saini says he learned a few things about serving all segments of society. After getting elected to the House of Commons, he wants to keep doing that, but with a larger customer base — about 102,433 people, to be exact.

That’s the most recent census information available for Kitchener Centre, the riding that Liberal MP-elect Saini will represent after winning last Monday’s federal election in his first run at public office.

As the co-owner of the independent Greenbrook Pharmacy, it should come as no surprise that nothing tops Saini’s list of priorities as he heads to Ottawa more than the need for a national pharmacare policy.

Fewer and fewer Canadians have benefits that cover the costs of prescription drugs and those rising out-of-pocket medicine expenses are the missing link in the country’s universal health care coverage, he said.

Raj Saini is a pharmacist, and co-owns one as well. While there is nothing wrong with this (and is admirable) the strange connections shown later are a cause for concern.

In 2019, Saini rehashed the same old Liberal campaign promise for universal drug coverage. In all fairness though, the LPC has been campaigning on it since 1993 and has never delivered on it.

3. Saini Lobbied By GAVI In 2019

Jason Clark, who works for the firm Crestview Strategy, lobbied Saini on March 8, 2018, on behalf of GAVI. GAVI is the Gates-funded Global Alliance for Vaccines and Immunizations. This was after Saini had introduced M-132, and prior to the Committee hearings in Parliament.

4. Other Pharma Lobbying MP Saini

All of these records can be verified by searching Raj Saini’s name in the Office of the Lobbying Commissioner of Canada. This is by no means all of the records, but shows a pretty good indication of who he has been speaking with.

Remember, it’s legal as long as it’s documented.

5. Canadian International Council

canadian.intl.council.1.bylaws
canadian.intl.council.2.certificate.of.continuance
canadian.intl.council.3.change.of.address
canadian.intl.council.4.change.of.directors

About
What makes the CIC unique is our network of 15 branches across seven provinces. This gives us a presence, in local communities, that is unparalleled in Canadian global affairs.
.
Thanks to this presence, Canadians from all walks of life, all ages, political opinions, and professions can discuss and learn about international affairs and contribute their views. In reflecting on the ideas and interests of a broad constituency of Canadians, the CIC demonstrates that our country’s foreign policy is not an esoteric concern of experts but benefits from direct citizen involvement.
.
As thousands of people join in an ongoing series of events and online discussions, the whole is greater than the sum of its parts. The result is a national conversation on our country’s role in the world.
.
We engage our members and the public to join the conversation through three types of activity: they can attend events, read our research and can share their opinions online.

Saini’s profile states that he is a Director at this organization (the Waterloo Branch). However, in searching him on the internal search, it doesn’t appear that he has contributed any publications to the organizations.

It’s interesting though: to be a Director at this group, which is looking for global solutions (on many issues). Saini introduced M-132, which will increase research and distribution of pharmaceuticals both in Canada and abroad. Certainly this is consistent with CIC’s agenda, but hard to tell if it is influencing the motion.

6. MP Saini Introduced M-132 In 2017

For a speech on passing M-132.
The text is below

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

Submissions Lodged
hesa.Structural.Genomics.Consortium.submission
hesa.Medicines.Patent.Pool.2018
hesa.Doctors.Without.Borders.2018
hesa.Canadian.Institutes.Of.Health.Research.2018
hesa.Fowke.Keith.University.Manitoba.2018
hesa.University.College.London.drug.prices.2018
hesa.Drugs.For.Neglected.Diseases.Initiative.2018
hesa.Moon.Suerie.2018
hesa.Yusuf.Salim.mcmaster
hesa.FIND.tb.alliance.gates.gavi.unitaid
hesa.Vlassoff.Carol.2018
hesa.Universities.Allied.For.Essential.Medecines.2018
hesa.Bruyere.Research.Institute.2018
hesa.Molyneux.David.2018

Dates Of Meetings
Thursday, September 27, 2018
Hesa.2018.September.27.evidence.transcript

Tuesday, October 2, 2018
Hesa.2018.October.2.evidence.transcript

Thursday, October 4, 2018
Hesa.2018.October.4.evidence.transcript

Tuesday, October 16, 2018
Hesa.2018.October.16.evidence.transcript

Thursday, October 18, 2018
Hesa.2018.October.18th.evidence.transcript

Tuesday, October 23, 2018
Hesa.2018.October.23.evidence.transcript

Thursday, October 25, 2018
Hesa.2018.October.25.evidence.transcript

REPORTS ISSUED
hesa.november.2018.report.to.parliament
hesa.government.response.march.2019

HOW THE FEDERAL GOVERNMENT COULD FOSTER INNOVATION IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN CANADA AND GLOBALLY
.
Witnesses suggested to the Committee that the federal government could address these challenges by increasing its investments in health research; promoting the creation of innovative alternative models of pharmaceutical R&D; and establishing strategic priorities for pharmaceutical R&D in line with both domestic and international population health needs.

(ii) Repurposing of Existing Drugs Dr. Keith Fowke, Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, told the Committee that federal funding of research focusing on examining ways to repurpose existing drugs that are safe, affordable and globally available to treat new conditions is another possible approach of reducing the costs of drug development, while ensuring affordable access to treatments. He explained to the Committee that his CIHR-funded research on HIV/AIDS examined the role that aspirin could play in preventing the spread of infection by reducing inflammation in cells in the genital tract that are susceptible to the HIV virus. His research showed that aspirin reduced the number of HIV target cells in the genital tract by 35%, which is paving the way for clinical trials in this area. Dr. Fowke recommended that CIHR continue to support innovative fundamental research that focuses on the repurposing of existing widely available generic drugs for the treatment of new conditions, an approach that reduces timelines and costs for R&D as these medications already exist

C. Develop a Strategic Framework for Federally Funded Health Research in Canada and Abroad
Finally, the Committee heard from both Drs. Nickerson and Yusuf that the federal government needs to develop a strategic framework that identifies priorities for health research funding that focuses on population health needs both in Canada and abroad. Though various federal government departments and agencies, including CIHR, the Public Health Agency of Canada and Global Affairs Canada have proposed priorities for federal health research funding both nationally and internationally, witnesses indicated that there is a need to review and better coordinate health research priorities across government to determine whether they are meeting population health needs. This priority setting would help identify areas where the federal government should target its investments in pharmaceutical R&D, which would leverage Canadian expertise across governments, universities, industry and civil society.

It cannot be overemphasized that these reports focus not only on cheap drugs for Canadians. They also are directed to the world at large. Presumably they will be sold at low rates, but since it’s not specified, they could be donated. Those are quotes from the November 2018 report that was released.

7. MP Saini Attended MIX Grand Opening

KITCHENER, ON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Medical Innovation Xchange (MIX), Canada’s first industry-led hub for medtech startups, celebrated its official launch and ribbon-cutting ceremony on Friday, January 10, 2020 at its Kitchener headquarters. Mr. Simon Kennedy, Deputy Minister, Innovation, Science & Economic Development provided the keynote address on what infrastructure is required to help retain and successfully scale Canadian medtech startups. Honoured guests included Kitchener Mayor Berry Vrbanovic, Member of Parliament Raj Saini, Member of Parliament Tim Louis, and industry leaders including prominent medtech CEOs, investors, hospital administrators, and government officials.

MIX, spearheaded in June 2019 by Intellijoint Surgical CEO Armen Bakirtzian, joins the powerful community within the Toronto-Waterloo Innovation Corridor to offer Canadian medtech companies an environment to grow locally and go to market globally. MIX Residents have a unique opportunity to retain ownership in early stages and succeed by leveraging MIX resources to avoid early stage pitfalls and post-prototype growing pains. The successes of Intellijoint Surgical, which celebrated its landmark 10,000th surgery in April of last year, and other successful Canadian medtech strategic advisors, help illuminate the path to bootstrapping as an alternative to acquisition by, for example, global medical device and pharmaceutical companies or packing up and moving operations to the United States.

“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”

Since the June 2019 announcement of its founding, MIX has already received dozens of inquiries from interested companies seeking to become part of the community. This will ensure Bakirtzian meets his commitment to fill the incubator’s office space with mature startups that would most benefit from peer-to-peer information exchanges over the course of their minimum 18-24 month occupancy. “We are committed to helping ‘grow our own’” says Bakirtzian, “and it starts with ensuring the most promising medtech startups have a home here at 809 Wellington Street where they can thrive and scale.”

MIX, the Medical Innovation Exchange, had it’s grand opening, on January 10, 2020. MP Saini was one of those in attendance. Since its launch, MIX has focused it’s services on the coronavirus epidemic, which happened very shortly afterwards. What a great, but coincidental timing this is. Here is another article covering the launch.

Bakirtzian and MIX’s inaugural Residents want to galvanize these realities for the medtech space and their many peers in the Kitchener-Waterloo area. Their vision also includes addressing tough questions about healthcare procurement policies, which impact the domestic healthcare market, and channels to access more mature sources of funding. They are keenly aware of the immediate and broader impact of their work.

“Canada is a place where innovation thrives – especially here in the Kitchener-Waterloo region.” says Raj Saini, MP for Kitchener Centre. “We offer one of the best economies in the world for new business ventures as well as small and medium enterprises. And medtech is an area rich in intellectual property — something Canadians lead at developing. But we need to improve at commercialization. Of patents filed in the past two years, 60% ended up with global companies within a year.”

“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”

MIX, the Medical Innovation Xchange, doesn’t actually do any research itself. Instead, it is a hub, or a place of centralization for others to research. Although this is just starting out, it will be very interesting to see where things lead.

8. Waterloo Corporate Welfare

Today, Raj Saini, Member of Parliament for Kitchener Centre, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for FedDev Ontario, announced a contribution of $2.57 million for Nicoya to scale up operations and accelerate growth into new markets.

“This FedDev Ontario investment in Nicoya is wonderful news for Waterloo Region. Twenty-nine good-paying, highly-skilled jobs will be added in our community, and our thriving biotechnology and health sciences cluster will be strengthened. Our government is committed to ensuring the competitiveness of our region both at home and abroad.”
– Raj Saini, Member of Parliament for Kitchener Centre

Off topic, but Saini handed out $2.57 million to create 29 jobs, or more than $88,000/per job. Great use of taxpayer money.

9. Issue With Saini’s Connection

Raj Saini is a licensed pharmacist, but he has also been lobbied by drug companies (among others) for his entire time in office. One of those parties was GAVI, the Global Vaccine Alliance that is largely financed by Bill Gates and his Foundation. On the surface at least, these look like a clear conflict of interest.

Saini introduced M-132, to get the House of Commons Standing Committee on Health to study ways to increase pharmaceutical research. The people who appeared before the Committee and give submissions have vested interests in seeing this go ahead.

M-132 could be totally coincidental, but consider how it looks. The motion is introduced in 2017, the hearings are in the fall of 2018, and the recommendations are adopted in March 2019. Later that year, Event 201 would be held and the coronavirus “pandemic” would be unleashed.

How convenient it is that the Parliamentary hurdles were cleared in time for drug researching to be advanced.

(1) https://rsaini.liberal.ca/
(2) http://archive.is/dz8Fx
(3) https://www.therecord.com/news-story/6058693-newly-elected-mp-raj-saini-ready-to-give-back-to-kitchener/
(4) http://archive.is/3U1YO
(5) https://openparliament.ca/debates/2017/9/25/raj-saini-1/
(6) http://archive.is/JFfTE
(7) https://thecic.org/about/governance/
(8) http://archive.is/YqLj5
(9) https://www.medicalinnovationxchange.com/
(10) http://archive.is/u3gUp
(11) https://www.globenewswire.com/news-release/2020/01/10/1969154/0/en/Medtech-CEO-Armen-Bakirtzian-paying-it-forward-by-creating-incubator-to-keep-IP-in-Canada-foster-Canadian-talent.html
(12) http://archive.is/TMp6H
(13) https://www.ept.ca/2020/01/tech-incubator-created-to-drive-medical-innovation/
(14) http://archive.is/vNeAz

CV#7: M-132 And International Pharma Research Grants In Canada

1. Other Articles On CV “Planned-emic”

CLICK HERE, for #0: Theresa Tam; archives; articles; lobbying.
CLICK HERE, for #1: piece on Bill Gates, Pirbright, depopulation.
CLICK HERE, for #2: Coronavirus research at U of Saskatchewan.
CLICK HERE, for #3: Gates; WHO, ID2020; GAVI; Vaccines.
CLICK HERE, for #4: Gates using proxies to push vaxx agenda.
CLICK HERE, for #5: Crestview Strategy, GAVI’s lobbying firm.
CLICK HERE, for #6: people GAVI/Crestview lobbied follow Gates.

http://www.lobbycanada.gc.ca

2. HESA Submissions, Evidence, Reports

Submissions Lodged
hesa.Structural.Genomics.Consortium.submission
hesa.Medicines.Patent.Pool.2018
hesa.Doctors.Without.Borders.2018
hesa.Canadian.Institutes.Of.Health.Research.2018
hesa.Fowke.Keith.University.Manitoba.2018
hesa.University.College.London.drug.prices.2018
hesa.Drugs.For.Neglected.Diseases.Initiative.2018
hesa.Moon.Suerie.2018
hesa.Yusuf.Salim.mcmaster
hesa.FIND.tb.alliance.gates.gavi.unitaid
hesa.Vlassoff.Carol.2018
hesa.Universities.Allied.For.Essential.Medecines.2018
hesa.Bruyere.Research.Institute.2018
hesa.Molyneux.David.2018

LINK To Parliamentary Study Main Page

3. Federally Funded Health Research: M-132

For a speech on passing M-132.
The text is below

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

4. Parliamentary Committee Meetings

Dates Of Meetings
Thursday, September 27, 2018
Hesa.2018.September.27.evidence.transcript

Tuesday, October 2, 2018
Hesa.2018.October.2.evidence.transcript

Thursday, October 4, 2018
Hesa.2018.October.4.evidence.transcript

Tuesday, October 16, 2018
Hesa.2018.October.16.evidence.transcript

Thursday, October 18, 2018
Hesa.2018.October.18th.evidence.transcript

Tuesday, October 23, 2018
Hesa.2018.October.23.evidence.transcript

Thursday, October 25, 2018
Hesa.2018.October.25.evidence.transcript

5. Reports Released To The Commons

In Canada and around the world, there is rising concern that innovative drugs produced by pharmaceutical companies are no longer affordable and are placing increasing strain on health care budgets. Policy makers have begun to examine ways that public funding for pharmaceutical research and development could address this issue. On 8 November 2017, the House of Commons adopted Private Members’ Business M-132, which requested that the House of Commons Standing Committee on Health (the Committee) “undertake a study on ways of increasing benefits to the public resulting from federally funded research, with the goals of lowering drug costs and increasing access to medicines, both in Canada and globally.”

On 16 and 18 October 2018, the Committee held two meetings as part of this study and heard from a range of witnesses including health researchers, health research funding organizations, patient groups and civil society organizations. Drawing on witness testimony and written submissions, this report examines the role the federal government can play in fostering pharmaceutical research and development both in Canada and globally to ensure that pharmaceutical drugs are accessible and affordable.

Note: Recommendations can be found starting at page 20 in the 2018 report released to the House of Commons.

HOUSE OF COMMONS STANDING COMMITTEE ON HEALTH CALLS ON THE GOVERNMENT OF CANADA TO FOSTER PHARMACEUTICAL RESEARCH AND DEVELOPMENT BOTH IN CANADA AND GLOBALLY THROUGH OPEN SCIENCE
Ottawa, November 26, 2018 –

Bill Casey, Chair of the House of Commons Standing Committee on Health, presented the Committee’s twentieth report today entitled, Towards Open Science: Promoting Innovation in Pharmaceutical Research and Development and Access to Affordable Medications both in Canada and Abroad.

The Committee’s study is in response to Member of Parliament Raj Saini’s Private Members’ Motion M-132, which requested that the Committee, “undertake a study on ways of increasing benefits to the public resulting from federally funded research, with the goals of lowering drug costs and increasing access to medicines, both in Canada and globally.”

In presenting the report to the House, Chair Bill Casey highlighted that “in our testimony, we heard loud and clear that more needs to be done to strengthen research and innovation in Canada. I thank Mr. Saini for bringing forth M-132, and for his efforts in ensuring that the Health Committee can hear why Canada must continue to be a leader in this field.”

Drawing on witness testimony heard over the course of two meetings held on 16 and 18 October 2018 and on 23 written submissions, the Committee’s report examines how increased federal investment in health research, across the continuum from fundamental to clinical research, would support the development of new medicines. However, witnesses also emphasized the importance of ensuring that federal funding in pharmaceutical research and development must also result in the creation of drugs that are affordable in Canada and abroad. Witnesses suggested that this could be achieved by fostering the creation of innovative models of pharmaceutical research that prioritize open science in both the development of new drugs and the repurposing of existing drugs. Witnesses explained that the Government of Canada could lead the way by developing a framework that sets priorities for pharmaceutical research and development and promotes open science through collaboration and leveraging of funding across governments, universities, health charities and private industry.

The Committee agrees with these findings and has included in its report nine recommendations that it believes will support the transformation of pharmaceutical research and development in Canada.

The announcement of the press release is here

Recommendation 1
That the Government of Canada create a specific funding mechanism for the development of clinical trial research and infrastructure in Canada through the Canadian Institutes of Health Research.
.
Recommendation 2
That the Government of Canada increase its funding for clinical trial research and infrastructure in Canada to 10% of the Canadian Institutes of Health Research’s budget to be on par with jurisdictions leading in this area, such as the United Kingdom and the United States.
.
Recommendation 3
That the Government of Canada explore ways to incentivize clinical trial research in Canada for pharmaceutical drugs and incentivize and support the production of those drugs in Canada at an advantaged price for Canada and provide venture capital for the proponent.
.
Recommendation 4
That the Canadian Institutes of Health Research attach a Global Access Licensing requirement to recipients of its research funding that wish to commercialize their research findings.
.
Recommendation 5
That the Canadian Institutes of Health Research include in its existing research and development programs support for the development of open science models of drug discovery.
.
Recommendation 6
That the Canadian Institutes of Health Research develop a framework for open science that supports collaboration and the leveraging of research funding among different partners in pharmaceutical research and development, including health charities, universities, governments, and private industry.
.
Recommendation 7
That Health Canada develop regulatory incentives for pharmaceutical companies that commit to open access to their research data and affordable prices for their products.
.
Recommendation 8
That the Government of Canada undertake a strategic review of its health-related research funding priorities across departments and agencies to enhance coordination, including Health Canada, Public Health Agency of Canada, Canadian Institutes of Health Research, Global Affairs Canada, and Innovation, Science and Economic Development Canada.
.
Recommendation 9
That the Government of Canada explore the feasibility of the public manufacturing of generic medicines.

In the follow-up report, the recommendations were formally adopted.

REPORTS TO PARLIAMENT
hesa.november.2018.report.to.parliament
hesa.government.response.march.2019

6. Committee Members

As provided by the report, these are the names and ranks of the Committee.

STANDING COMMITTEE ON HEALTH

CHAIR

  • Bill Casey

VICE-CHAIRS

  • Marilyn Gladu (lobbied by GAVI)
  • Don Davies
  • MEMBERS

    • Ramez Ayoub
    • Doug Eyolfson
    • Raj Grewal
    • Ben Lobb
    • Ron McKinnon
    • John Oliver (Parliamentary Secretary — Non-Voting Member)
    • Sonia Sidhu
    • Len Webber

    OTHER MEMBERS OF PARLIAMENT WHO PARTICIPATED

    • Randy Boissonnault
    • Terry Duguid
    • Randy Hoback
    • Tom Kmiec
    • Christine Moore
    • Raj Saini (lobbied by GAVI)
    • Dave Van Kesteren

    CLERK OF THE COMMITTEE

    • Marie-Hélène Sauvé

    Why is the list of the Committee Members here? Well, once you see who some of the connections are, it will likely make the report findings a lot more suspicious.

    7. Committee Members & Pharma Lobbying

    The above screenshots came from information provided in the Office of the Lobbying Commissioner of Canada. These are far from exhaustive, but show a snapshot at the lobbying that is going on in Canada. Members of this Parliamentary Committee are being lobbied by various drug companies. It’s not difficult to see that this is done in order to influence them.

    8. Conflict Of Interest Here

    The same committee members who are recommending that Canada undertake more research for pharmaceuticals are the same ones who are being lobbied by pharmaceutical companies. It’s not difficult to piece it together.

    CV #6: Many Bureaucrats GAVI & Crestview Strategy Lobbied Already Followed Gates

    1. Other Articles On CV “Planned-emic”

    CLICK HERE, for #0: Theresa Tam; archives; articles; lobbying.
    CLICK HERE, for #1: piece on Bill Gates, Pirbright, depopulation.
    CLICK HERE, for #2: Coronavirus research at U of Saskatchewan.
    CLICK HERE, for #3: Gates; WHO, ID2020; GAVI; Vaccines.
    CLICK HERE, for #4: Gates using proxies to push vaxx agenda.
    CLICK HERE, for #5: Crestview Strategy, GAVI’s lobbying firm.

    http://www.lobbycanada.gc.ca

    2. GAVI/Crestview Communication Reports

    The following bit was covered in the previous piece. There are 20 communications reports on file over the last two years where Crestview Strategy has lobbied the Federal Government on behalf of GAVI, the Global Vaccine Alliance.

    Dates of Communications Reports
    (1) 2018 March 8
    (2) 2018 March 9
    (3) 2018 March 9
    (4) 2018 October 9
    (5) 2018 October 9
    (6) 2018 October 9
    (7) 2018 October 10
    (8) 2018 October 10
    (9) 2018 October 10
    (10) 2019 June 11
    (11) 2019 June 11
    (12) 2019 June 11
    (13) 2019 June 12
    (14) 2019 June 12
    (15) 2019 June 12
    (16) 2020 January 28
    (17) 2020 January 29
    (18) 2020 January 29
    (19) 2020 January 29
    (20) 2020 January 30

    No, these aren’t duplications. The registry indicates multiple reports on these dates. Here are screenshots of the actual listings.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented. While that is likely the case, we need evidence to make that conclusion though.

    The focus of this article will be on the bureaucrats and politicians themselves who are being lobbied. Who are they, what is their game, and is there any conflict of interest? As will be shown below, many of these politicians and bureaucrats may have already been on board prior to meeting with Gates’ proxies.

    It is the next logical step. Crestview Strategy, and their ties to GAVI have been posted, but what about the people they lobbied? What is their take on things?

    3. Sumin Lee, PHAC

    CLICK HERE, for Sumin Lee’s LinkedIn page.
    http://archive.is/L8Gei

    4. Tammy Bell, PHAC

    CLICK HERE, for Tammy Bell’s LinkedIn page.
    http://archive.is/HckL5

    5. Carol Malko, OIAHP

    >

    CLICK HERE, for Carol Malko’s LinkedIn page.
    http://archive.is/z0p1L

    6. Geoffroi Montpetit, Global Affairs

    CLICK HERE, for Geoffroi Montpetit’s LinkedIn page.
    http://archive.is/CL83i

    7. Hanna Button, Global Affairs

    CLICK HERE, for Hanna Button’s LinkedIn page.
    http://archive.is/mu0g5

    8. Sabina Saini, Chief Of Staff, Health Canada

    CLICK HERE, for Sabini Saini’s LinkedIn page.
    http://archive.is/pxGTS

    9. Raj Saini, MP Kitchener Center

    CLICK HERE, for Raj Saini’s Liberal MP website.
    http://archive.is/dz8Fx

    10. Javid Dharas, Special Adviser, PMO

    CLICK HERE, for Javid Dharas’ LinkedIn page.
    http://archive.is/uoJWN

    11. Sean Phelan, Office Of Official Opposition

    CLICK HERE, for Sean Phelan’s LinkedIn page.
    http://archive.is/485te
    Sean’s endorsement letter from Rob Nicholson

    12. Elvanee Veeramalay, Stakeholder Rel., OLO

    CLICK HERE, for Elvanee Veeamalay’s LinkedIn page.
    http://archive.is/tGdVH

    13. Kathleen Davis, Prime Minister’s Office

    CLICK HERE, for Kathleen Davis’ LinkedIn page.
    http://archive.is/l1kQi

    14. Rebecca Caldwell, Director Min. Guilbeault

    CLICK HERE, for Rebecca Caldwell’s LinkedIn page.
    http://archive.is/yZTLQ

    15. Suzanne Taylor, Global Affairs

    CLICK HERE, for Suzanne Taylor’s LinkedIn page.
    http://archive.is/eO4x7

    16. Monique Lugli, CoS, Health Minister

    CLICK HERE, for Monique Lugli’s LinkedIn page.
    http://archive.is/sun1F

    17. Karina Rolland, Office Of Leader Of Opposition

    CLICK HERE, for Karina Rolland’s LinkedIn page.
    http://archive.is/KsPlC

    18. Dara Lithwick, Chief Of Staff, Heritage

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.
    >CLICK HERE
    , for Dara Lithwick’s LinkedIn page.
    http://archive.is/DhBG0

    19. Yanique Williams, Policy Director, SoW

    CLICK HERE, for Yanique Williams’ LinkedIn page.
    http://archive.is/8AaRl

    20. Did They Already Support Gates?

    Going through the LinkedIn profiles of the bureaucrats whom Crestview Strategy (on behalf of GAVI) have been lobbying, many of them show an interest in Bill Gates, his wife Melinda, or their foundation. It’s worth asking if those profiles have been updated recently to reflect their meetings, or whether they “already” were on board with Gates’ vaccination agenda.

    Would be nice to get an answer on this, but we likely never will. So take the above information for what it’s worth.

    CV #5: Crestview Strategy, The Lobbying Firm Advocating For GAVI’s Vaxx Agenda

    Influence peddling in Canada is more than just a full time job. It requires hiring additional staff, and having additional offices in other cities.

    1. Other Articles On CV “Planned-emic”

    (A) https://canucklaw.ca/cv-0-corona-plandemic-lobbying-deleted-resources-cl-listings-theresa-tam-canadas-hoaxer-zero
    (B) https://canucklaw.ca/cv-1-coronavirus-patent-by-pirbright-institute-funded-by-gates-foundation-climate-change-scam-15/
    (C) https://canucklaw.ca/cv-2-coronavirus-research-at-usask-gates-foundation-undp-funded-ivi-douglas-richardson/
    (D) https://canucklaw.ca/cv-3-bill-gates-vaccines-un-who-gavi-id2020-us-cdc-all-involved/
    (E) https://canucklaw.ca/cv-4-gates-foundation-lobbied-trudeau-using-proxies-into-accepting-vaccine-agenda/

    2. Context For This Piece

    A previous piece address the attempts by GAVI (the Global Vaccine Alliance) to lobby the Federal Government into pushing the vaxx agenda. GAVI used a lobbying firm called Crestview Strategy to do their dirty work

    In going through the profiles of the Crestview Strategy staff, it becomes disturbingly obvious that many of them have political connections. In fact, many of them were involved in recent elections, getting politicians into office.

    So what happens after their candidates gain power? Do they owe favours? Is there any quid pro quo? Or do people go their own way? It seems that the ties run deep. This list doesn’t even include everyone.

    3. Crestview’s Corporate Documents

    Crestview Annual Return (1)
    Crestview Registered office & Directors (3)
    Crestview.Certificate.Of.Amalgamation (2)
    crestview.directors.change.2019

    4. Crestview Lobbied For GAVI/Gates Foundation

    Crestview was lobbying the Federal Government at the end of January, 2020, even as the public is being told that there is nothing to worry about. Interesting.

    The following bit was covered in the previous piece. There are 20 communications reports on file over the last two years where Crestview Strategy has lobbied the Federal Government on behalf of GAVI, the Global Vaccine Alliance.

    Dates of Communications Reports
    (1) 2018 March 8
    (2) 2018 March 9
    (3) 2018 March 9
    (4) 2018 October 9
    (5) 2018 October 9
    (6) 2018 October 9
    (7) 2018 October 10
    (8) 2018 October 10
    (9) 2018 October 10
    (10) 2019 June 11
    (11) 2019 June 11
    (12) 2019 June 11
    (13) 2019 June 12
    (14) 2019 June 12
    (15) 2019 June 12
    (16) 2020 January 28
    (17) 2020 January 29
    (18) 2020 January 29
    (19) 2020 January 29
    (20) 2020 January 30

    No, these aren’t duplications. The registry indicates multiple reports on these dates.

    These are just the 20 reports that are on file with the Office of the Lobbying Commissioner. It’s fair to assume that there have been many, many more talks that aren’t documented.

    Also, going through the profiles of the Crestview Strategy staff, it is troubling to see just how many of them have political connections. While people are allowed to vote and advocate as they please, there comes the serious question of conflicts on interest.

    5. Crestview Lobbyist Ashton Arsenault

    Prior to joining Crestview, Ashton worked as a political aid on Parliament Hill where he was responsible for parliamentary affairs and issues management for the Minister of National Revenue. Prior to that, he worked as a legislative researcher in the Official Opposition Office in Prince Edward Island. He continues to volunteer in electoral politics at the federal level.

    Ashton has been involved in politics for several years, serving as a campaign manager for a Conservative candidate in the 2015 General Election. As well, he served as the University of Prince Edward Island’s Chair of Council from 2011-2012.

    Among other roles, Arsenault helped with the 2015 election campaign of CPC candidate Andy Wang.

    6. Crestview Lobbyist Zakery Blais

    Zakery Blais is a Consultant with Crestview Strategy. With a focus on Canada-U.S. relations and international development, Zakery services clients globally.

    His experience spans both the public and private sectors. He previously worked as a Legislative Assistant to a Canadian Member of Parliament, providing strategic political and communications advice. Prior to joining Crestview Strategy, Zakery also worked in various capacities in public affairs, including as an analyst focused on the energy and natural resources sectors.

    That is from his profile on the Crestview Strategy webpage.

    Fun fact: Blais was an assistant for David Lametti, a former Parliamentary Secretary, and currently the Attorney General of Canada. While Crestview CLAIMS it doesn’t operate on a who-you-know basis, the current lobbyist pushing this is the Attorney General’s former assistant. Not exactly arms length, is it?

    7. Crestview Lobbyist Andrew Brander

    With more than 15 years of experience in federal, provincial and municipal politics, Andrew brings an instinctive understanding of government and media relations, strategic communications and issues management.

    Andrew spent a decade in Ottawa under the Harper Government, during which time he worked for Canada’s Minister of Transport, Minister of Labour and Minister of Natural Resources. On various occasions, he was recognized by his colleagues, appearing in The Hill Times Terrific 25 survey of top parliamentary staffers. During his time in opposition politics, he worked for the Finance Critic and served as Chief of Staff for the Deputy Leader of the Official Opposition. Andrew served as senior staff in the Ford Government, most recently as Director of Communications for The Honourable Rod Phillips, currently Ontario’s Finance Minister.

    Brander spent a decade in Harper’s Government, and has also been in the Ontario Provincial Government.

    8. Crestview Lobbyist Melissa Caouette

    Melissa worked previously for a global law firm as a government affairs and public policy professional and as a Special Assistant to the Premier of Alberta. Melissa has been involved in a number of municipal, provincial and federal campaigns and is active within her community.

    Interesting. She has been an assistant for the Alberta Premier, and has been involved in municipal, provincial and federal elections campaigns.

    9. Crestview Lobbyist Nathan Carr

    Prior to joining Crestview Strategy, Nathan led the digital campaigns practice at a prominent public relations and strategic communications agency in Toronto. As an early adopter of machine-learning in digital advertising, Nathan has helped break new ground in data-driven mobilization for political campaigns and public affairs clients alike. A skilled campaigner, Nathan has led teams to winning outcomes through federal, provincial, and municipal elections.

    Carr was involved in the 2015 Federal election. In fact, he was the President of the High Park Liberal Riding Association.

    10. Crestview Lobbyist Alex Chreston

    Prior to joining the Crestview team, Alex served as a Senior Advisor to Toronto Mayor John Tory focusing on communications and events. He also spent a decade working at Queens Park where he served as a senior aide in the Office of the Leader of the Official Opposition under both John Tory and Tim Hudak.

    Additionally, Alex has worked in strategic planning and execution on campaign teams for multiple provincial and local elections.

    Chreston is yet another lobbyist with political connections. He has ties to the Ontario Conservatives, and to Toronto candidates.

    11. Crestview Lobbyist Jason Clark

    Prior to joining the Crestview Team, Jason has worked in public policy development and advocacy and engagement campaigns, most recently for Engineers Without Borders Canada. Since arriving in Ottawa he has worked work a wide range of Canadian Non-profit organizations on international development and trade issues. Previously, Jason managed one of the largest public engagement campaigns on climate change, energy and sustainability in Great Britain, working in partnership with all levels of government, business, industry and trade associations, the public sector and civil society. Jason has also worked with female entrepreneurs and social enterprises in Lesotho, Africa.

    [Jason Clark] volunteered for several Ottawa-area Liberal Party of Canada candidates during the 2015 election campaign.

    That is from his profile page with Crestview Strategy.

    12. Crestview Lobbyist Hal Danchilla

    Almost every political event in Alberta over the last 30 years has been shaped, advised, managed, directed or informed by Hal Danchilla. He has managed leadership and election campaigns nationally, provincially and locally including as a Chief of Staff and political advisor during the Klein administration, managing the successful underdog campaign of Stephen Mandel to become Mayor of Edmonton, the leadership and national campaign for Stockwell Day and the Canadian Alliance, and most recently a trusted advisor and campaign strategist for Jason Kenney.

    Interesting. It claims that Danchilla is involved in all political affairs in Alberta over the last 3 decades. So when he lobbies it must have considerable clout.

    13. Crestview Lobbyist Jordan Devon

    Prior to joining Crestview, Jordan served as a communications intern in the United Nations office of the World Jewish Congress in Geneva, Switzerland.

    He is an experienced communications professional, having staffed political campaigns at the municipal, provincial, and federal levels, as well as in the office of a Member of Parliament.

    Quite the globalist here. He served as an intern at the United Nations for the office of the World Jewish Congress. Involved in campaigns at the local, provincial and federal levels. Helped get a current MP elected.

    13. Crestview Lobbyist Grant Goldberg

    Grant is a consultant based out of Crestview Strategy’s Toronto office. Prior to joining Crestview Strategy, Grant served as an intern in the United Kingdom where he assisted both the leader of a major political party and an opposition member in the House of Lords. Grant has also worked in international affairs, primarily with a London-based think-tank, and in the field of political risk.

    Grant has been involved in Canadian politics and has worked on campaigns in both his local community and across Ontario.

    Goldberg has been involved in politics for a long time. This is both in the UK, and across Ontario. It seems to be a portable skill.

    14. Crestview Lobbyist Gabriela Gonzalez

    Prior to joining the Crestview team, Gabriela worked at Queen’s Park for four years and is a long-time organizer with the Ontario Liberal Party and the Liberal Party of Canada. Most recently, she worked as a Senior Communications and Operations Advisor to Ontario’s Minister of Economic Development and Growth. Prior to that role, she was the Toronto Regional Advisor at the Liberal Caucus Service Bureau. She also worked for Premier Kathleen Wynne in her role as Minister of Agriculture and Food and Minister Jeff Leal as the Minister of Rural Affairs.

    Gonzalez has extensive connections to both the Ontario Liberals and the Federal Liberals, and has helped out in Cabinet. A true political insider with extensive connections.

    15. Crestview Lobbyist Susie Heath

    Susie Heath is a Senior Consultant at Crestview Strategy based out of the Ottawa Office. Susie brings with her almost a decade of experience in communications, stakeholder engagement, government relations and political campaigns. Prior to joining Crestview, Susie spent a year practicing government relations in Ottawa, and prior to that, over three years in a senior national public affairs role at a global ridesharing company. During this period, she led the communications strategy which resulted in the regulation of ridesharing in communities across Canada.

    Previously, Susie spent over six years at Queen’s Park, where she served as Senior Communications Advisor and Press Secretary to the Minister of Finance, as well as in a number of senior communications and legislative advisor roles to various Ministers.

    She spent 6 years in Queen’s Park, as a Press Secretary for the Minister of Finance, and for other Ministers. Has also spent time in politics in Ottawa. Yet another who goes between provincial and federal politics.

    16. Crestview Lobbyist Matthew John

    Matthew John is Crestview Strategy’s Chief Operating Officer, bringing with him twenty years of experience in government, business strategy and public affairs.

    In a career that has included leadership roles in both the private and public sector, Matthew previously served as Manager of Outreach in the office of Prime Minister Stephen Harper and has held executive positions in political parties at the federal and provincial level.

    John was previously in the Prime Minister’s Office, and has served parties at both the Provincial and Federal level.

    17. Crestview Lobbyist Gail Kelly

    She has been a senior consultant with Crestview Strategy (formerly Canadian Strategy Group) since 2013. Prior to that she spent over six years working in provincial politics with the Progressive Conservative Association of Alberta. Her vast knowledge of the political process and understanding of provincial politics assists her in connecting the needs of clients with the opportunities presented by Government. She has worked with clients from numerous sectors, including not-for-profits, industry associations, corporations, and local businesses, achieving outcomes through strategy development, execution and messaging. Gail holds a BA from McGill University in Economics and Political Science.

    Six years working with the Progress Conservative Association of Alberta. These people cross party lines and seem to be connected to everyone. Not only are a lot of these Crestview employees involved in politics, but many seem to have come from McGill University. A lot of politicians go there too.

    18. Crestview Lobbyist Ella Klein

    Ella was born and raised on Bowen Island and worked as a visitor experience guide at Bowen Island Tourism. Ella coordinated community events and provided support to visitors to the Island. Ella has volunteered on political campaigns at the provincial and federal levels in both British Columbia and Ontario. Ella continues to be involved with local political organizations, participating in canvassing, advocacy activities, and event planning.

    Klein has political ties to both Ontario and BC. In fact, her profile indicates a prolific interest in politics, and now she is in a position to do something about it.

    19. Crestview Lobbyist Joseph Lavoie

    Joseph has more than a decade of campaign and public affairs experience, joining Crestview after years of honing his craft in the United States, Canada and abroad. As a senior political staffer, Joseph served Canada’s former Minister of Foreign Affairs, John Baird before serving former Prime Minister Stephen Harper as his Director of Strategic Communications.

    Lavoie was a staffer for then Cabinet Minister John Baird, and then a staffer for Prime Minister Stephen Harper.

    20. Crestview Lobbyist Madison Leach

    Prior to joining Crestview Strategy, Madison worked as Office Manager and Executive Assistant to Ontario’s Attorney General and Minister of Francophone Affairs where she played a lead role in day to day operations and logistics for the Attorney General and staff, and provided planning support for Ministerial tour.

    Madison has worked in various roles within the Ontario Public Service, including at the Ontario Ministry of Agriculture, Food, and Rural Affairs in policy, program and corporate areas. More recently, Madison provided executive support at the Ministry of the Attorney General to the Chief Administrative Officer and played a key role during the July 2018 government transition, onboarding Attorney General’s office staff and acting as a liaison between the Minister’s office and the Ministry. Madison has also worked for Sodexo as Manager of Operations.

    Leach held various roles including support for the Ontario Attorney General’s Office.

    21. GAVI Lobbying Multiple Parties

    22. Rob Silver, Katie Telford’s Husband

    Liberal strategist and former pundit Rob Silver said Monday he has left the government relations firm he helped create, citing his wife’s position as Justin Trudeau’s chief of staff.

    “Effective Dec. 31, 2015 I am no longer a shareholder or employee of Crestview Strategy,” Silver said in an email Monday afternoon.

    Silver was a partner in the Toronto- and Ottawa-based public affairs agency that, among other things, lobbies the federal government on behalf of clients.

    Rob Silver, husband of Katie Telford, Trudeau’s Chief-of-Staff, helped start up Crestview Strategy, the lobbying firm that GAVI hired to push the vaccine agenda.

    23. Crestview Secures $800M Grant To GAVI

    Trudeau’s Government gave $800 million to GAVI, the Gates funded vaccine alliance. I don’t suppose the Silver-Telford relationship and the incessant lobbying had anything to do with it.

    24. Political Cronies In Lobbying

    There are others, of course. However, the article will stop here, as the point has already been made.

    Political staffers and party figures shouldn’t be in the business of lobbying. Aside from the obvious conflict of interest, it does the public a huge disservice. These influence peddlers should be called out for what they are.

    Keep in mind, the firm of Crestview Strategy has lobbied the Federal Government at least 20 times on behalf of GAVI, the Global Vaccine Alliance that is funded by the Gates Foundation. Gates is using an organization he funds to hire Liberal cronies (Zakery Blais and Jason Clark) to lobby the Liberal Party of Canada.

    I suppose if the Conservatives were in power, Crestview would be using CPC cronies to do the lobbying. After all, they have enough of them on staff.

    CV #2: Coronavirus Research At USask: Gates Foundation, UNDP Funded IVI, Douglas Richardson

    1. Other Articles On CV “Planned-emic”

    (A) https://canucklaw.ca/cv-0-corona-plandemic-lobbying-deleted-resources-cl-listings-theresa-tam-canadas-hoaxer-zero
    (B) https://canucklaw.ca/cv-1-coronavirus-patent-by-pirbright-institute-funded-by-gates-foundation-climate-change-scam-15/

    2. Important Links

    (1) https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/vwRg?cno=3653&regId=895048
    (2) https://archive.is/iRv5L
    (3) https://www.mckercher.ca/
    (4) https://archive.is/VtpqF
    (5) https://twitter.com/VIDOInterVac
    (6) https://news.usask.ca/articles/research/2020/usask-vido-intervac-and-international-vaccine-institute-collaborate-on-covid-19-work.php
    (7) http://archive.is/Fcplz
    (8) https://news.usask.ca/articles/research/2019/usasks-vido-intervac-and-south-koreans-international-vaccine-institute-to-undertake-scientific-exchanges.php
    (9) http://archive.is/jgKDU
    (10) http://www.un-rok.org/about-un/offices/ivi/
    (11) http://archive.is/FIdw8
    (12) https://en.wikipedia.org/wiki/International_Vaccine_Institute
    (13) http://archive.is/S7ZkF
    (14) https://www.vido.org/news/maternal-immunization-may-protect-newborns-from-whooping-cough-u-of-s-vido-study
    (15) http://archive.is/ABYl3

    3. Context For This Piece

    With the (alleged) coronavirus pandemic and the public panic, one has to ask if vaccines will become mandatory in Canada. After all, powerful people have floated the idea of doing just that. But now would be a good time to follow the money and see where it goes.

    Bill Gates, the vaccine fetishist, has his hands in vax development in Canada as well. In fact, he has been financing the University of Saskatchewan for many years. InterVac, which is part of USask, has been partnered with the International Vaccine Institute in South Korea (IVI) for quite some time. IVI is funded by the United Nations Development Programme (UNDP).

    Gates pushes for vaccines across the world, but refuses to vaccinate his own children. That should tell you everything you need to know about him.

    An interesting connection is a longtime Liberal donor and lobbyist, Douglas Richardson. He has been trying to get funding for InterVac. That’s right: he is lobbying to have more of your tax dollars given to InterVac (and USask) to partner with IVI and the Gates Foundation.

    4. Richardson A Longtime Liberal Donor

    Date Of Donation Amount $ Recipient
    Jan 26, 2005 545.00 LPC
    May 20, 2005 1000.00 LPC
    Jul 17, 2006 1000.00 LPC
    Jul 17, 2006 1000.00 Michael Ignatieff
    Sep 22, 2006 250.00 LPC
    Sep 22, 2006 250.00 Hedy Fry
    Nov 15, 2006 995.00 LPC
    May 27, 2010 1100.00 LPC
    Dec 29, 2011 59.52 LPC
    Dec 31, 2011 970.00 LPC
    Aug 14, 2012 1178.70 LPC
    Mar 8, 2013 90.00 Justin Trudeau
    Sep 27, 2013 1186.88 LPC
    Oct 16, 2014 1178.38 LPC
    Apr 25, 2016 1,470.52 LPC
    Nov 27, 2017 1,468.42 LPC
    Nov 27, 2018 1,459.55 LPC
    Nov 27, 2019 1000.00 LPC

    5. Richardson’s Public Offices Held

    Check out the PUBLIC OFFICES HELD for more information on Douglas Richardson. This is what was disclosed to the Lobbying Commissioner’s Office.

    Policy Advisor to the Hon. Otto Lang
    Minister Responsible for the Canadian Wheat Board, Agriculture Canada
    June 1971 to August 1971

    Policy Advisor to the Minister of Justice
    Department of Justice, Justice Canada
    June 1972 to August 1972

    Chief of Staff to the Minister of Finance
    Finance Canada, Department of Finance
    February 1982 to August 1983

    Chief of Staff and Principal Secretary to the Leader of the Opposition
    House of Commons, Leader’s Office
    March 1985 to September 1987

    Vice Chairman and Trustee of the Canadiana Fund
    Heritage Canada, Cultural properties
    April 2003

    6. Richardson’s Lobbying Efforts

    And for the University of Saskatchewan more broadly:

    Who does Douglas Richardson lobby?

    • Agriculture and Agri-Food Canada (AAFC)
    • Canada Revenue Agency (CRA)
    • Canadian Food Inspection Agency (CFIA)
    • Canadian Grain Commission (CGC)
    • Canadian Institutes of Health Research (CIHR)
    • Canadian International Trade Tribunal (CITT)
    • Canadian Security Intelligence Service (CSIS)
    • Environment and Climate Change Canada (ECCC)
    • Federal Economic Development Agency for Southern Ontario (FedDev)
    • Finance Canada (FIN)
    • Fisheries and Oceans Canada (DFO)
    • Global Affairs Canada (GAC)
    • Health Canada (HC)
    • House of Commons
    • Impact Assessment Agency of Canada (IAAC)
    • Infrastructure Canada (INFC)
    • Innovation, Science and Economic Development Canada (ISED)
    • National Research Council (NRC)
    • Natural Resources Canada (NRCan)
    • Natural Sciences and Engineering Research Council (NSERC)
    • Prime Minister’s Office (PMO)
    • Privy Council Office (PCO)
    • Public Health Agency of Canada (PHAC)
    • Public Safety Canada (PS)
    • Public Services and Procurement Canada (PSPC)
    • Senate of Canada
    • Western Economic Diversification Canada (WD)

    7. VIDO-InterVac On Twitter

    For some of its announcements, check out InterVac’s Twitter account, and see what it has been up to.

    8. International Vaccine Institute

    The International Vaccine Institute (IVI) is an independent, nonprofit, international organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.

    Created initially as an initiative of the UN Development Programme (UNDP), IVI began formal operations as an independent international organization in 1997 in Seoul, Republic of Korea. Currently, IVI has 35 countries and the World Health Organization (WHO) as signatories to its Establishment Agreement. The Institute has a unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions.

    While not the most reliable source, Wikipedia can provide background information into an organization that’s already nicely laid out.

    9. InterVac Partners W/UN Funded IVI

    The International Vaccine Institute (IVI) is a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP). It is among the few organizations in the world dedicated to vaccines and vaccination for global health.

    IVI is involved in all aspects of bringing a vaccine to reality: discover new technologies to make new vaccines or improve existing ones; develop promising vaccine candidates for licensure and World Health Organization (WHO) prequalification by transferring the technology to manufacturers and partnering with them on clinical development; deliver licensed vaccines in low-income countries by generating scientific data on the need for vaccines and the impact of vaccination for decision makers; building capacity in vaccinology in developing countries through technical assistance and training to promote self-sufficiency and sustainability in vaccines and vaccination; and building partnerships in Asia and globally for vaccines and global health.

    This has long been a partner with InterVac (University of Saskatchewan). It is funded by the United Nations. However, it does get some hefty grants, from the Bill and Melinda Gates Foundation.

    The International Vaccine Institute (IVI) of South Korea, a world-renowned international organization founded by the United Nations Development Programme, is collaborating with VIDO-InterVac at the University of Saskatchewan (USask) to better understand the virus causing the COVID-19 pandemic and to develop vaccines and potential treatments.

    “The worldwide importance of the ongoing COVID-19 pandemic seems to naturally align our two vaccine institutes and provides the opportunity to build on this partnership,” said Jerome Kim, director general of the IVI based in Seoul.

    The two research centres are partnering on a $180,000 project that will look at virus replication, immune responses, and the effect of antivirals and other medicines to combat COVID-19.

    The USask funding for the initiative comes from the USask International Blueprint’s Global Innovation Fund and VIDO-InterVac.

    South Korea has been one of the countries hardest hit by this virus. IVI has formed a number of partnerships with companies and governments to advance vaccines against the SARS-CoV-2 virus that causes COVID-19.

    The funding collaboration builds on a long-standing relationship between the two institutes, as well as on a recent memorandum of understanding (MOU) signed between USask President Peter Stoicheff and Director-General Kim in South Korea in October of 2019. Read more about the MOU here: https://news.usask.ca/articles/research/2019/usasks-vido-intervac-and-south-koreans-international-vaccine-institute-to-undertake-scientific-exchanges.php

    University of Saskatchewan VIDO-InterVac is partnered with the International Vaccine Institute, a United Nations funded group that operates out of South Korea. An interesting partnership indeed. But what is this “memorandum of understanding” that is referenced here?

    10. More On InterVac/IVI Partnership

    Located on the Seoul National University campus, IVI is a world-renowned organization of the United Nations Development Programme dedicated to vaccines and vaccination for global health. USask’s VIDO-InterVac is a global leader in infectious disease research and vaccine development and has commercialized eight vaccine technologies, six of which are world firsts.

    The MOU, signed this week in Seoul by USask President Peter Stoicheff, VIDO-InterVac associate director Paul Hodgson, and IVI director general Jerome Kim, establishes a formal scientific exchange program between the two organizations in infectious disease research and vaccine development, and enables students, post-doctoral fellows and scientists to complete training and learning exchanges. Saskatchewan Premier Scott Moe was on hand to witness the signing ceremony.

    “Infectious diseases are one of the top causes of morbidity and mortality worldwide, and along with vaccine hesitancy (reluctance or refusal to be vaccinated or to have one’s children vaccinated), comprise six of the World Health Organization’s top 10 threats to global health in 2019,” said Hodgson.

    The two organizations have worked together for more than a decade. Multi-million dollar joint research funded by the Bill and Melinda Gates Foundation under one of the foundation’s original 43 grand challenges in global health program resulted in the discovery and patenting of a novel adjuvant (an immune response booster) for vaccines.

    Very interesting. The University of Saskatchewan and the International Vaccine Institute, (which is funded by the UN), have worked together for over a decade, and the Gates Foundation has provided multi-million dollars to further finance vaccine research.

    Also, consider the date: October 15, 2019. What else was going on around that time?

    Right. It was Event 201, the pandemic “simulation” held on October 18, 2019, just 3 days later. But sure that is just a strange coincidence. Nothing to see here people.

    11. InterVac Research Funded By Gates Fdn

    For some more chilling information on InterVan and Bill Gates, a search here will net more disturbing details.

    In 2006 there was Maternal Immunization May Protect Newborns from Whooping Cough U of S VIDO Study.

    In 2009 there was VIDO-InterVac Major Partner in HIV/AIDS Vaccine Pilot Plant Bid.

    In 2018, Gerds was named Director. There was the Grand Challenges in Global Health projects funded by the Bill and Melinda Gates Foundation. As part of this research, the group developed a novel vaccine platform for neonates that is being used to develop vaccines for pertussis and respiratory syncytial virus.

    12. Vaccine Research Is Here In Canada

    Vaccine research for this and other “pandemics” isn’t something that is happening off in some distant world. It’s here now, and has been operating in Canada for many years. People need to know who the players are, and who is connected to who.

    Pierre Beaudoin: Bombardier Chairman; Power Corporation Director

    1. Important Links

    (1) https://canucklaw.ca/desmarais-power-corp-canadas-globalist-politicians-bombardier-loblaws/
    (2) https://canucklaw.ca/desmarais-power-corp-linked-to-air-canada-agenda-2030-trudeau-foundation/
    (3) https://www.powercorporation.com/en/governance/board-directors/#pierre-beaudoin
    (4) http://archive.is/PBros
    (5) https://www.bombardier.com/en/about-us/management/biography-page.bio-pierrebeaudoin.html
    (6) http://archive.is/W4jJ2
    (7) https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/vwRg?cno=344715&regId=862759
    (8) http://archive.is/U0LbK
    (9) https://nationalpost.com/news/politics/at-least-20-people-including-bombardier-head-donated-maximum-allowed-to-both-liberals-and-conservatives-in-2018
    (10) http://archive.is/1jUEf
    (11) https://www.theglobeandmail.com/report-on-business/who-canadas-ten-most-generous-political-donors-have-contributed-to/article26793752/
    (12) http://archive.is/M52l7
    (13) https://nationalpost.com/news/politics/conservative-government-covered-expenses-for-top-ceos-travelling-with-stephen-harper-on-china-tour
    (14) http://archive.is/ThMon
    (15) https://globalnews.ca/news/3346938/trudeau-bombardier-aid-executives/
    (16) http://archive.is/Xhb0v

    2. Beaudoin Lobbies As Bombardier Chair

    Subject Matter Details
    .
    Grant, Contribution or Other Financial Benefit
    Obtain financial support from Canada with respect to various research and development initiatives.
    Obtain financial support from Industry Canada under the Strategic Aerospace and Defence Initiative for research and development.
    .
    Grant, Contribution or Other Financial Benefit, Policies or Program
    Management of ongoing projects reated to various research and development initiatives.
    .
    Legislative Proposal, Bill or Resolution
    Enhance research and development tax incentives under the Income Tax Act, including Investment Tax Credits (ITC)
    Obtain support from Export Development Canada (EDC) with respect to transportation equipment procurement.
    .
    Legislative Proposal, Bill or Resolution, Policies or Program
    Tax legislation and policies affecting the innovation and manufacturing of global firms operating in Canada.
    .
    Policies or Program
    Canada’s participation in the Organisation for Economic Co-Operation Development consensus financing guidelines pertaining to sales financing framework.
    Canada’s support for the development of standard for rail technology.
    Canada’s support for the development of the rail industry.
    Canadian Multi-Mission Aircraft Program with regard to procurement of aircraft.
    Define appropriate levels for aircraft certification at Transport Canada.
    Economic and trade agreements with respect to equal market access with other countries.
    Establish appropriate regulations for export permits and controlled goods.
    Expansion of various air services agreements under Canada’s Blue Sky Policy.
    Obtain support from Canada to enable Export Development Canada (EDC) to provide customer financing of aircraft.
    The protection and promotion of Canada’s access to global markets.
    .
    Policies or Program, Regulation
    Canada’s participation in potential plurilateral discussions around the WTO on aerospace and ways to strengthen them.
    Canada’s support for the development of a skilled workforce.
    .
    Regulation
    Changes to the civil aviation regulations with respect to private operators.

    Government Institutions
    Bank of Canada
    Canada Economic Development for Quebec Regions
    Canada Revenue Agency (CRA)
    Canadian Commercial Corporation (CCC)
    Employment and Social Development Canada (ESDC)
    Environment and Climate Change Canada (ECCC)
    Export Development Canada (EDC)
    Finance Canada (FIN)
    Global Affairs Canada (GAC)
    House of Commons
    Immigration, Refugees and Citizenship Canada (IRCC)
    Infrastructure Canada (INFC)
    Innovation, Science and Economic Development Canada (ISED)
    National Defence (DND)
    National Research Council (NRC)
    Prime Minister’s Office (PMO)
    Privy Council Office (PCO)
    Public Safety Canada (PS)
    Public Services and Procurement Canada (PSPC)
    Transport Canada (TC)
    Treasury Board Of Canada Secretariat (TBS)

    Please note: that Bombardier has been lobbying the Federal Government a lot longer than Beaudoin himself has been registered as a lobbyist. However, since 2015, he has gotten his own hands dirty with it.

    While Beaudoin himself is listed 18 times (18 communications reports) with the Federal Government and Federal officials, Bombardier itself is listed in 809 communications reports.

    3. Anthony Graham: Bombardier/Power Corp

    Anthony Graham is a Director at Power Corporation, at Bombardier. He shares the same conflict of interest that Pierre Beaudoin has. Graham is also the Vice Chairman of Whittington Investments (busy man), which owns the Weston Loblaws Group.

    4. Beaudoin Donates To Both LPC/CPC

    In an emailed statement, a spokesperson for the Liberals highlighted the “growing success” of their grassroots fundraising and emphasized the implementation of transparency rules around the party’s fundraising events.

    A spokesperson for the Conservative party said if someone “chooses to donate to multiple parties, they’re within the rules to do just that.” He said due to the volume of donations the party receives, the number of dual-party donors was not particularly notable.

    People who max out their individual donations to both parties are “hedging their bets” ahead of the fall election, according to Duff Conacher, the head of Democracy Watch, an ethics watchdog.

    “With those donations, they are able to at least buy access to the top people in the parties, and having that access gives them a chance to have influence over their decisions,” Conacher said.

    An article by the National Post highglighted how many wealthy and influential people were donating to both the Liberals and Conservatives. The rationale being, that regardless of who wins, those donors will have access to the politicians at the top.

    The National Post isn’t wrong about their claim. Looking up “election financing” on the Elections Canada website confirms the allegations.

    While it was nice of the National Post to bring this issue up, they missed the chance to do a spectacular piece of investigative journalism by not going further and publishing all of their findings. Oh well.

    5. Beaudoin Always Playing Both Sides

    And in the year 2019, Beaudoin donated the same amount to both the Conservative Party, and the Liberal Party. In 2017, Beaudoin again donated to both parties. In fact, he did so on the same day. Playing both sides it seems.

    Notice the pattern here? Beaudoin routinely donates to both major Federal parties. It’s almost as if he expects access and favours, regardless of who wins.

    Note: There are several Pierre Beaudoins but this will focus on the one I believe is him. (Disclaimer: he may be using multiple addresses in the donations). This is under the address of WESTMOUNT QC H3Y1K8.

    Date Amount $ Received
    2006 Feb 21 $2000 CPC
    2006 Apr 30 $2500 LPC
    2006 Sep 29 $1000 Bob Rae
    2006 Sep 29 $1000 LPC
    2008 Oct 07 $1100 CPC
    2009 Mar 03 $1000 CPC
    2010 Apr 06 $1000 CPC
    2011 Sep 09 $1100 CPC
    2012 Mar 16 $1200 CPC
    2013 Feb 01 $1200 CPC
    2013 Mar 11 $600 J. Trudeau
    2013 Dec 28 $1197 LPC
    2014 Nov 26 $1200 CPC
    2014 Nov 27 $1178 LPC
    2015 Apr 10 $1500 CPC
    2015 Apr 17 $1200 LPC
    2015 Oct 02 $300 LPC
    2015 Oct 02 $1500 LPC
    2016 Feb 19 $1500 CPC
    2016 Feb 23 $1500 LPC

    Again, there are other Pierre Beaudoins (who may be him) with different postal codes. However, all of the above donations came from a single postal code.

    6. Donations From Desmarais Family

    This chart ONLY includes Helene Desmarais, wife of Paul Desmarais Jr. and Chair of the Montreal Economic Institute.

    Date Amount $ Received
    2004 Jun 09 $5000 CPC, Vernier
    2004 Jun 30 $5000 LPC
    2005 Jan 20 $5000 CPC
    2005 Jan 31 $5000 LPC
    2006 Apr 30 $5000 LPC
    2006 Apr 30 $1000 LPC
    2006 Apr 30 $2000 LPC
    2006 Dec 31 $5000 LPC
    2007 Jan 01 $1000 CPC
    2007 Feb 08 $1000 CPC
    2008 Sep 30 $500 Maxime Bernier
    2009 Jan 21 $1000 CPC
    2009 Feb 19 $1100 LPC
    2010 Apr 30 $1100 CPC
    2010 May 31 $1171 LPC
    2010 Jun 01 $1100 LPC
    2011 Mar 14 $923 Beauce Riding Ass’n
    2012 Apr 09 $901 Beauce Riding Ass’n
    2014 Mar 19 $1000 Beauce Riding Ass’n
    2014 Mar 26 $500 LPC
    2014 Apr 24 $1200 CPC
    2015 Feb 20 $5000 Beauce Riding Ass’n
    2015 May 28 $1000 CPC
    2015 Nov 09 $1200 LPC
    2016 Mar 18 $1500 LPC
    2016 Oct 13 $1000 Maxime Bernier
    2016 Oct 17 $300 CPC
    2017 May 12 $1550 CPC
    2017 May 15 $1500 CPC
    2018 Mar 16 $1500 LPC
    2018 Mar 22 $1575 CPC

    And these donations, which are clearly directed to both the Liberal and Conservative parties, is just one member of the Desmarais family.

    7. Desmarais & Beaudoin Big Donors

    Desmarais family – $290,000
    To the Liberals: $190,000
    To the Conservatives: $100,000
    The influential clan behind Quebec’s Power Corp. of Canada has donated $290,000 over the past decade, slightly favouring the Liberals. The total includes donations from patriarch Paul Desmarais, who died in 2013, wife Jacqueline, sons Paul Jr. and André, who now jointly lead the company, along with daughters Louise and Sophie as well as several grandchildren.

    Laurent Beaudoin and the Bombardier family – $213,000
    To the Liberals: $132,000
    To the Conservatives: $81,000
    The Quebec family that controls Bombardier Inc. has donated more than $200,000, with the largest share going to the Liberals. Donors include chairman emeritus Laurent Beaudoin, wife Claire Bombardier Beaudoin, son Pierre, who stepped down as CEO this year, along with other relatives who make up the controlling shareholders of Bombardier.

    The Globe & Mail did a piece on major donors and how they tend to donate to both parties. The Beaudoin and Desmarais families are the two biggest, but there are other players.

    It doesn’t take much to understand the reason behind this: these families want to have influence, regardless of which party wins power. Paying off all sides is apparently how you do it.

    8. Beaudoin Took Trip With Harper

    Corporations and associations — including Bombardier, Cenovus Nuclear Energy, the Canadian Association of Petroleum Producers and Cameco — confirmed that the government paid for portions of the expenses, with the amount varying from firm to firm.

    “We’ll leave it to the government to confirm those expenses. We won’t comment any further on that,” Isabelle Rondeau, director of communications at Bombardier, said of CEO Pierre Beaudoin’s participation.

    Pretty influential to get an all inclusive trip with the PM, to be covered by taxpayers. And considering how often Bombardier needs to be bailed out, it is hardly a success story.

    9. Why Maxime Bernier Bailed Out Bombardier

    As stated earlier, Pierre Beaudoin holds dual roles: one as the Chairman of Bombardier, another as a Director of Power Corporation, owned by the Desmarais family. The conflict of interest here cannot be understated.

    Andre Desmarais and Paul Desmarais Jr. are the sons of Paul Desmarais Sr. They control Power Corporation now. Helene Desmarais is Paul Jr.’s wife, and is the Chair of the Montreal Economic Institute. Side Note: Andre Desmarais is ex-PM Chretien’s son-in-law. He married Frances Chretien. Other side note: Peter MacKay used to date Sophie Desmarais.

    Let’s take a look at someone Helene Desmarais has been donating to, and the riding associations she has been donating to. Bear in mind, she has donated 5 times to riding associations (according to Elections Canada records), once to Laurier Saint-Marie, and 4 times to Beauce.

    Date Amount $ Received
    2008 Sep 30 $500 Maxime Bernier
    2011 Mar 14 $923 Beauce Riding Ass’n
    2012 Apr 09 $901 Beauce Riding Ass’n
    2014 Mar 19 $1000 Beauce Riding Ass’n
    2015 Feb 20 $5000 Beauce Riding Ass’n
    2016 Oct 13 $1000 Maxime Bernier

    Explaining the Bombardier bailout (when Maxime Bernier was Industry Minister) isn’t difficult. Let’s connect the dots here:

    Bombardier Chairman, Pierre Beaudoin works for ==>
    Paul Desmarais Jr, who’s married to ==>
    Helene Desmarais, who runs the ==>
    Montreal Economic Institute, which employed ==>
    Maxime Bernier, who became the ==>
    Industry Minister, who has power to ==>
    Hand out taxpayer money

    Here’s an even simpler connection:
    Pierre Beaudoin ==> Desmarais Family ==> Bernier

    Of course, that is just one bailout that Bombardier has received over the years. Because of the Beaudoin/Desmarais connection, and Desmarais owning so many politicians, the bailout money keeps coming in.

    10. Bombardier Exec Pocket Bailout Money

    Total compensation for the Montreal-based manufacturer’s top five executives and board chairman Pierre Beaudoin was US$32.6 million in 2016, up from US$21.9 million the year before, according to a proxy circular ahead of Bombardier’s annual meeting on May 11

    CEO Alain Bellemare received US$9.5 million, up from US$6.4 million in 2015, including US$5.2 million in share and option-based awards and a US$1 million salary. His annual bonus almost doubled to US$2.36 million.

    Beaudoin’s total compensation increased to US$5.25 million from US$3.85 million a year earlier.

    Global News reported that Bombardier in 2017 will be getting a $372 million “loan” package. Interesting how the executives who run Bombardier into the ground get larger bonuses. Beaudoin himself will be getting an extra $10 million, about a 50% increase. Not bad for being such a screwup.

    11. Political Connections = Bailouts

    Pierre Beaudoin and Anthony Graham are both Directors at Power Corporation (owned by the Desmarais family), and govern Bombardier. This is a huge conflict of interest.

    Bombardier has spent significant time and money lobbying politicians. Pierre Beaudoin has taken it upon himself to do some of the lobbying personally. Beaudoin also has a lengthy track record for donating to both major parties — meaning he gets access regardless of who wins.

    These bailouts are little more than political money laundering. Taxpayer funds go to Bombardier, and executives use part of it to increase their bonuses.

    All of this needs to stop.